Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.61 CAD | +2.55% | 0.00% | -51.94% |
May. 14 | Transcript : Aptose Biosciences Inc., Q1 2024 Earnings Call, May 14, 2024 | |
May. 14 | Aptose Biosciences Q1 Net Loss Falls, on Lower Expenses | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-51.94% | 19.25M | |
+67.53% | 63.85B | |
-0.77% | 41.83B | |
+44.98% | 40.47B | |
-10.87% | 27.17B | |
+13.30% | 26.52B | |
-22.79% | 18.69B | |
+4.70% | 12.73B | |
+24.10% | 12.11B | |
+27.41% | 12.07B |
- Stock Market
- Equities
- APS Stock
- News Aptose Biosciences Inc.
- Aptose Biosciences Third-Quarter Loss Widens on Higher R&D Spending